The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study
- 31 December 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (14) , 1951-1957
- https://doi.org/10.1016/0959-8049(93)90451-k
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Occurrence of epidermal growth factor receptors in benign and malignant ovarian tumors and normal ovarian tissues: an immunohistochemical studyZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Long-term survival in ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Presence of epidermal growth factor (EGF) receptor and proliferative response to EGF in six human ovarian carcinoma cell linesInternational Journal of Gynecologic Cancer, 1991
- Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), Insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin.Journal of Clinical Investigation, 1990
- INHIBITION OF OESTRADIOL PRODUCTION BY EPIDERMAL GROWTH FACTOR IN HUMAN GRANULOSA CELLS OF NORMAL AND POLYCYSTIC OVARIESClinical Endocrinology, 1990
- Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors.The Journal of cell biology, 1989
- Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomasGynecologic Oncology, 1988
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- Presentation of therapeutic results in carcinoma of the female pelvis: Experience of the Annual Report on the Results of Treatment in Carcinoma of the Uterus, Vagina, and OvaryGynecologic Oncology, 1976